{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04542304",
            "orgStudyIdInfo": {
                "id": "56566"
            },
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Efficacy of Diuretics in Kidney Disease",
            "officialTitle": "Efficacy of Diuretics in Kidney Disease",
            "therapeuticArea": [
                "Nephrology and Renal Diseases"
            ],
            "study": "efficacy-of-diuretics-in-kidney-disease"
        },
        "statusModule": {
            "statusVerifiedDate": "2022-09",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-03-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2020-08-27",
            "studyFirstSubmitQcDate": "2020-09-08",
            "studyFirstPostDateStruct": {
                "date": "2020-09-09",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2022-09-29",
            "lastUpdatePostDateStruct": {
                "date": "2022-10-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Tammy Lisa Sirich",
                "investigatorTitle": "Assistant Professor of Medicine",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Stanford University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will determine the efficacy of diuretics in patients with chronic kidney disease.",
            "detailedDescription": "Participants with chronic kidney disease will undergo two 1-week study periods (diuretic versus placebo) separated by 1-2 weeks of washout in a cross-over design. Blood and urine samples will be collected at the end of each study period to determine the effect on urine output and to assess the kidney clearance and levels of uremic solute. Participants will weigh themselves daily and complete quality of life questionnaires."
        },
        "conditionsModule": {
            "conditions": [
                "Chronic Kidney Disease",
                "End Stage Renal Disease"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "OTHER",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 50,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Metolazone then placebo",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Metolazone will be taken orally during the first week, followed by washout of 1-2 weeks, then placebo will be taken the following week.",
                    "interventionNames": [
                        "Drug: Metolazone"
                    ]
                },
                {
                    "label": "Placebo then Metolazone",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo will be taken orally during the first week, followed by washout of 1-2 weeks, then metolazone will be taken the following week.",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Metolazone",
                    "description": "Participants will be given a metolazone for the 1-week study period.",
                    "armGroupLabels": [
                        "Metolazone then placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Participants will be given a placebo for the 1-week study period.",
                    "armGroupLabels": [
                        "Placebo then Metolazone"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in urine output",
                    "description": "average volume of urine produced in 24 hours",
                    "timeFrame": "Change from baseline urine output at 1 week for each study arm"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in kidney clearance of uremic solutes",
                    "description": "kidney clearance of uremic solutes in ml/min",
                    "timeFrame": "Change from baseline kidney clearance of uremic solutes at 1 week for each study arm"
                },
                {
                    "measure": "Change in quality of life questionnaire score",
                    "description": "Kidney Disease Quality of Life 36 Questionnaire (KDQOL36)",
                    "timeFrame": "Change from baseline quality of life score at 1 week for each study arm"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* stable chronic kidney disease patients able to provide consent\n* stable dialysis patients who produce urine and able to provide consent\n\nExclusion Criteria:\n\n* use of antibiotics for last two months or expected antibiotic use\n* recent hospitalization or other event resulting in instability of food intake",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tammy L Sirich, MD",
                    "role": "CONTACT",
                    "phone": "650-493-5000",
                    "phoneExt": "68321",
                    "email": "tsirich@stanford.edu"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University",
                    "status": "NOT_YET_RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tammy Sirich, MD",
                            "role": "CONTACT",
                            "phone": "650-493-5000",
                            "phoneExt": "68321",
                            "email": "tsirich@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                },
                {
                    "facility": "VA Palo Alto Health Care System",
                    "status": "RECRUITING",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tammy Sirich, MD",
                            "role": "CONTACT",
                            "phone": "650-493-5000",
                            "phoneExt": "68321",
                            "email": "tsirich@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007674",
                    "term": "Kidney Diseases"
                },
                {
                    "id": "D000051436",
                    "term": "Renal Insufficiency, Chronic"
                },
                {
                    "id": "D000007676",
                    "term": "Kidney Failure, Chronic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014570",
                    "term": "Urologic Diseases"
                },
                {
                    "id": "D000052776",
                    "term": "Female Urogenital Diseases"
                },
                {
                    "id": "D000005261",
                    "term": "Female Urogenital Diseases and Pregnancy Complications"
                },
                {
                    "id": "D000091642",
                    "term": "Urogenital Diseases"
                },
                {
                    "id": "D000052801",
                    "term": "Male Urogenital Diseases"
                },
                {
                    "id": "D000051437",
                    "term": "Renal Insufficiency"
                },
                {
                    "id": "D000002908",
                    "term": "Chronic Disease"
                },
                {
                    "id": "D000020969",
                    "term": "Disease Attributes"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10698",
                    "name": "Kidney Diseases",
                    "asFound": "Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10699",
                    "name": "Kidney Failure, Chronic",
                    "asFound": "End Stage Renal Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26717",
                    "name": "Renal Insufficiency, Chronic",
                    "asFound": "Chronic Kidney Disease",
                    "relevance": "HIGH"
                },
                {
                    "id": "M26718",
                    "name": "Renal Insufficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M17319",
                    "name": "Urologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M2875",
                    "name": "Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27093",
                    "name": "Female Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M14127",
                    "name": "Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M8399",
                    "name": "Female Urogenital Diseases and Pregnancy Complications",
                    "relevance": "LOW"
                },
                {
                    "id": "M27095",
                    "name": "Male Urogenital Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6147",
                    "name": "Chronic Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M22700",
                    "name": "Disease Attributes",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BXS",
                    "name": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000008788",
                    "term": "Metolazone"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000004232",
                    "term": "Diuretics"
                },
                {
                    "id": "D000045283",
                    "term": "Natriuretic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000049993",
                    "term": "Sodium Chloride Symporter Inhibitors"
                },
                {
                    "id": "D000049990",
                    "term": "Membrane Transport Modulators"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7411",
                    "name": "Diuretics",
                    "relevance": "LOW"
                },
                {
                    "id": "M11761",
                    "name": "Metolazone",
                    "asFound": "Attention Deficit Hyperactivity Disorder (ADHD)",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M26152",
                    "name": "Sodium Chloride Symporter Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "NaAg",
                    "name": "Natriuretic Agents"
                }
            ]
        }
    },
    "hasResults": false
}